Document Detail


Immunotherapy for patients with persistent allergic rhinitis unsatisfied with free chronic pharmacotherapy.
MedLine Citation:
PMID:  16750119     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Chronic pharmacotherapy is recommended to patients with persistent moderate-severe (PM-S) allergic rhinitis (AR). The cost of pharmacotherapy is the main barrier to achieve symptoms control.
AIMS OF THE STUDY: To determine the benefits of mite subcutaneous immunotherapy (SIT) in patients with PM-S AR not satisfied with chronic pharmacotherapy received free of charge.
METHODS: Open study with seven (7) patients with PM-S AR not satisfied with chronic pharmacotherapy. Prior to enrollment patients had received monthly for more than five months and free of charge, optimal pharmacotherapy. We compared, off pharmacotherapy, symptoms and quality of life (QOL) before and during SIT.
RESULTS: Mite SIT improved nasal symptoms, non nasal symptoms and QOL. Off pharmacotherapy patients reported adequate control of symptoms and were satisfied.
CONCLUSIONS: Not all patients with PM-S AR are satisfied with chronic pharmacotherapy, even if medication is received free of charge. SIT control symptoms and satisfies patients with PM-S AR unsatisfied with free chronic pharmacotherapy.
Authors:
José E Gereda Solari; Juan Loo; Antonio Felices; Jorge Casas
Related Documents :
17250699 - Identification of a plane pollen lipid transfer protein (pla a 3) and its immunological...
16259309 - Short term reactions to acupuncture--a cross-sectional survey of patient reports.
8210959 - Allergy caused by light-cured ear-moulds.
6733889 - Epithelial damage in nasal polyps.
17686109 - Relationship between aria classification and drug treatment in allergic rhinitis and as...
16394759 - Assessment of immunologic mechanisms for flare reactions to synvisc.
21661349 - Thorough clinical evaluation of skin, as well as oral, genital and anal mucosa is benef...
857579 - Lysozyme activity in cerebrospinal fluid. studies in inflammatory and non-inflammatory ...
2536479 - Varicella in pediatric orthotopic liver transplant recipients.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Allergologia et immunopathologia     Volume:  34     ISSN:  0301-0546     ISO Abbreviation:  Allergol Immunopathol (Madr)     Publication Date:    2006 May-Jun
Date Detail:
Created Date:  2006-06-05     Completed Date:  2006-10-31     Revised Date:  2014-07-29    
Medline Journal Info:
Nlm Unique ID:  0370073     Medline TA:  Allergol Immunopathol (Madr)     Country:  Spain    
Other Details:
Languages:  eng     Pagination:  102-6     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Adult
Animals
Anti-Allergic Agents / economics,  therapeutic use
Antigens, Dermatophagoides / therapeutic use
Budesonide / economics,  therapeutic use
Cetirizine / economics,  therapeutic use
Desensitization, Immunologic* / economics
Drug Costs
Female
Humans
Income
Insurance Coverage
Insurance, Pharmaceutical Services
Loratadine / economics,  therapeutic use
Male
Patient Satisfaction
Pregnadienediols / economics,  therapeutic use
Prospective Studies
Pyroglyphidae / immunology
Questionnaires
Rhinitis, Allergic, Perennial / drug therapy,  therapy*
Chemical
Reg. No./Substance:
0/Anti-Allergic Agents; 0/Antigens, Dermatophagoides; 0/Pregnadienediols; 51333-22-3/Budesonide; 7AJO3BO7QN/Loratadine; 83919-23-7/mometasone furoate; YO7261ME24/Cetirizine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Mycoplasma infections
Next Document:  Acceptance survey of a fast dissolving tablet pharmaceutical formulation in allergic patients. Satis...